Back

The value of cardiac iodine-123-metaiodobenzylguanidine scintigraphy in postinfarction heart failure patients qualified for implantable cardioverter defibrillator in follow up of 2-5 years

12 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session I Nuclear Imaging ESC Premium Access ICNC 2019

About the speaker

Photo
Doctor Anna Teresinska

National Institute of Cardiology, Warsaw (Poland)

49 More presentations in this session

Presentation thumbnail
Evaluation of diastolic function in patients with pulmonary hypertension due to left heart disease assessed by TDI and compared with MDCT
Doctor D. Kristo (Thessaloniki, GR)
Abstract
Presentation thumbnail
Low dose coronary angiography on 640-slices computed tomography. experience at tertiary care hospital of sindh pakistan
Mr S. Aziz (Karachi, PK)
Presentation thumbnail
Current utility and provision of FFRCT
Doctor A. Asher (London, GB)
Abstract
Presentation thumbnail
The effect of myocardial bridge on the amount of atherosclerotic plaques and on the local hemodynamic changes
Doctor S. Borzsak (Budapest, HU)
Abstract
Presentation thumbnail
Changing clinical practice of downstream investigations following CTCA; Impact of CTFFR in a large tertiary cardiothoracic centre.
Doctor S. Iqbal (Manchester, GB)
Abstract Slides

Access the full session

Session thumbnail
Poster session I

The Event

Event poster

ICNC 2019

12 May - 14 May 2019
You may be interested in
thumbnail
Congress Presentation
My Top 5 Nuclear Cardiology Papers of 2025
thumbnail
Congress Presentation
The exciting future of nuclear cardiac imaging
thumbnail
Congress Presentation
Novel PET tracers: paving the way for accessible cardiac PET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources